Bai et al. have found that MicroRNA-214-3p inhibits ATF4 in HCC cells HepG2 and Hep3B, accelerates ferroptosis, and can be used as a new therapeutic target or prognostic marker for HCC treatment (Bai et al., 2020). Here, ATF4 is linked to hepatocellular carcinoma.